CA1181490A - Ion mobility limiting iontophoretic bioelectrode - Google Patents
Ion mobility limiting iontophoretic bioelectrodeInfo
- Publication number
- CA1181490A CA1181490A CA000396679A CA396679A CA1181490A CA 1181490 A CA1181490 A CA 1181490A CA 000396679 A CA000396679 A CA 000396679A CA 396679 A CA396679 A CA 396679A CA 1181490 A CA1181490 A CA 1181490A
- Authority
- CA
- Canada
- Prior art keywords
- bioelectrode
- ions
- skin
- tissue
- receptacle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
Abstract
A B S T R A C T
A bioelectrode for use in the iontophoretic delivery of ions into the skin or tissue of a person includes either a recep-tacle or a composition of material suitable for holding ions to be delivered, a metallic foil disposed on one side of the receptacle or composition of matter, and a coupling device for electrically coupling the foil to an electrical source.
The other side of the receptacle or composition of material is for placement against a person's skin or tissue so that ions may be delivered thereinto. The receptacle or composi-tion of material both include features or characteristics which inhibit the migration of ions laterally therein, i.e., in a direction generally parallel to the surface of the skin or tissue, but which allow migration in a direction generally perpendicular to the surface of the skin or tissue, and in particular from the metal foil toward the person's skin or tissue. The advantage of this capability is to provide a substantially uniform movement of ions into the skin or tissue over surface area of contact of the bioelectrode with the skin.
A bioelectrode for use in the iontophoretic delivery of ions into the skin or tissue of a person includes either a recep-tacle or a composition of material suitable for holding ions to be delivered, a metallic foil disposed on one side of the receptacle or composition of matter, and a coupling device for electrically coupling the foil to an electrical source.
The other side of the receptacle or composition of material is for placement against a person's skin or tissue so that ions may be delivered thereinto. The receptacle or composi-tion of material both include features or characteristics which inhibit the migration of ions laterally therein, i.e., in a direction generally parallel to the surface of the skin or tissue, but which allow migration in a direction generally perpendicular to the surface of the skin or tissue, and in particular from the metal foil toward the person's skin or tissue. The advantage of this capability is to provide a substantially uniform movement of ions into the skin or tissue over surface area of contact of the bioelectrode with the skin.
Description
ION MOBI~ITY LIMITING
IONTOPHORETIC BIOELECTRODE
This invention relates to an iontophoretic bioelectrode method and apparatus and more particularly to such a method and apparatus in wh.ich migration of ions from the apparatus to a person's skin or skin barrier is inhibited in certain direction~.
Iontophoresis is a technique of delivering ions into a pe-son's ~0 skin or tissue by placing a solution or other medium contain-ing the ions in contact with the skin, and applying electric current to the medium. The solution or medium containing the ions is typically carried by a first bioelectrode po.uch or receptacle. Ions are caused to migrate from the ion car.ryi.ng medium through the skin or tissue by the applicat.i.on of the electric current to the medium, and by placement against the.
skin o:E a second bioelectrode within some proximity oE the ~irst bioelectrode and the application of current of opposite polarity to the second bioelectrode. Th.is technique has been discussed in a number of prior art patent.s including U.S.
Patent No. 4,141,359 and 4,166,457. Examples of bioelectrodes which are generally useful for making electrical contact with the skin are described in UOS~ Patent Nos. 3,862,633 3,945,384 and 3,g73,557 o 1 There nave ~een several bioelectrGde proposals for carrying the ion solution or medium and placing it in pro~imity with the skin including provision o~ a receptacle with a wetable barrier on one side thereof. The wetable barrier or wall is covered until time of use and then uncovered for placement against the skin. T,hen, upon application of the electrical current, the lons migrate through the wall into the skin.
Another proposed arrangement involves the use of a receptacle ha~ing a microporous mem~rane on one side thereof which may be placed in contact with a person's skin. The membrane is selected so that it will not leak prior to use, but will allow migration of ions therethrough to the skin upon application of an electric current to the ion-carrying solution. With this arrangement, less care need be given to storage, trans-port and use of the receptacle since the ion containin~
fluid will not leak as it is used.
One of the principal problems with the prior art devices has been the problem of the bioelectrode producing burns at the site of application of medications. If the current to the bioel~ctrode is too high, the resistance of the skin or tissue may result in burns or other tissue damage. F~urther, once the skin or tissue is burned, the resistance at the site of the burn decreases allowing for an increase in current flow and thus ion migration at that site and this compo~mds the danger of serious burns to the skin or tissue. lf a blemish or cut ~xists somewhere at the location of contact of the bioelectrode with the skin or tissue, then the ions tend to migrate toward and concentrate at the blemish thereby increasing the danger of ~ burn at that site.
One approach to reducing the likelihood of burns to the skin or tissue is to simply reduce the amount of current applied ~5 to the bioelectrode. This, however, increases the treatment time for the patient since lower current flow requires longer 1 periods of applica'ion to reach the same degree of ion pen-etration. Of course, it would be desirable to both minimize the treatment time and minimize the likelihood of burns to the patient Erom the treatment.
It is an object of the invention to provide a new and improved bioelectrode for use in the ion~ophoretic delivery of ions into the skin or tissue of a personO
It is another object of the invention to provide such a bio-electrode in which the likelihood of burns to the skin or tissue is reduced It is a further object of the invention to provide such a bioelectrode wherein the lateral mobility of the ions in the elec-trode is inhibited.
It is an additional object of the invention to provide a bioelectrode for delivering ions into the skin or tissue of a person uniformly over a certain skin or tissue surface area regardless of local variations in skin impedance such as that caused by previous tissue damage.
It is also an object of the invention, in accordance with one aspect thereof to provide a bioelectrode adapted ~o minimize the chance of chemically induced iontophoretic ph burns.
The above and other objects of the invention are realized in a bioelectrode structure which includes a holder for hold-ing ions to be deLivered, one side of which is Eor placement against the person's skin or tissue. The holder is adapted to inhibit movement of ions in a direction yenerally parallel to the surface of the skin or tissue while allowing movement toward the side which is placed against the skin or tissue.
1 Also included is an elec~rically conduc~ive sheet of material a-ttached to and covering a substantial portion of ~he other side of the holder, and an electrical conductor coupled to the sheet of material for connection to an electrical source.
Electrlcal current is supplied ~y the conductor tv the sheet of materi.al to.cause the ions contained in the holder to migrate towards the side of the holder in contact with the skin. Since lateral movement of ions is inhibited by the holder (due to the longer current path lengths), the liKe~
lihood of burning is decreased since movement of ions to concentrate at one place is inhibited.
The holder can be adapted to inhibit the lateral movement of ions either by including structure within the holder to physically guide the ions or by proper selection and dimen-sioning of the ion holding material to enhance migration in one direction while inhibiting migration in another direction.
An example of the latter is gel material preloaded with ions.
By incorporation of an appropriate phosphate buffer in the gel material, chemically induced iontophoretic ph burns can better be avoided.
In the drawings:
The ahove and other objects, features and ad~antages of the inven~ion will become apparent from a consideration of the following detailed descrip-tion presented in connection with the accompanying drawings in which: 0 FIG. 1 is a perspective view of a bioelectrode made in accordance with the principl~-s of the present invention;
FIG~ 2 is a side, cross-sectional view of the bioelectrode 3~ of FIG. l;
1 FIG. 3 is a perspective view of another embodiment of the invention;
FIG. 4 is a side, cross-sectiGnal view of the bioelectrode of FIG. 3; -FIG. S is a top, cross-sectional view of one embodimant of the interior structure of the bioelectrode of FIG. 3;
FIG. 6 is a top, cross-sectional view of another embodiment of the interior structure of the bioelectrode o FIG. 3; and FIG. 7 is a top, cross-secti.onal view of still another ernbodiment of t;~e interior structure of -the bioelectrode of FIg. 3.
Referring now to the drawings:
Referring to the drawings there are shown several embodiments of an iontophoresis device made in accordance with the present invention. FIGS. 1 and 2 show a bioelectrode 2 composed o an upper cover 4 which may be made of pla~tic, treated paper, or other suitable covering material. Mounted in the co~er 4 is the male part 8 of a conventional metallic snap used on clothin~ and the like. The snap 8 includes an upwardly projecting nipple 8a which protrudes throuyh the cover 4 so that contact may be had with the corresponding female part o the snap or other suitable conductor. The nipple 8a is joined to a base portion 8b which is disposed on the under-neath side of the cover 4.
Afixed to the underneath side of the cover 4 in contact with the base portion 8b of the snap 8 is a piece of flexible foil 12 made of alumlnum ~r other electrically conductive rnaterial.
1 The foil 12 is in electrical contact with the snap 8 so that any electrical current applied to the snap 8 will flow to the foil 12. Affixed to the underneath side of the foil 12 is a sheet of iontophoresis gel 16 such as karaya g~lm, other pol~-S sacharide gels, or similar hydrophillic aqueous gels capableof carrying ions. Specific examples of such gels include polyvinyl alcohol, polymethyl pyrollidine, me~hyl cellulose, polyacrylamide, polyhemas, and polyhema derivatives, etc.
The perimeter of the gel 16 is substantially coterminous with the foil 12 as shown in the drawings. The gel selected should have nonirritating properties to avoid irrita~ing the person's skin or ~issue, sui.table viscosity and surfactant properties to ohtain good electrical contact with the skin or tissue, and the ability to act as a carrier mediwm for the ions. The lower surface of the gel 16 is for placement in contact with a person's skin or tissue for the iontophoretic treatment.
In order to minimize the chance of chemically induced ionto-phoretic ph burns in the surface tissues and the underlying tissues in the area of placement of the device, a phosphate buffer, such as mono-basic and/or di-basic sodium phosphate, is included in the gel material 16. Advantageously, a ph of about six will be provided in the gel.
The gel 16 is dimensioned so that ion migration is enhanced in a direction normal to the person's skin or tissue, and general~y inhibitied in a direction parallel to the person's skin. It has been found that a thickness-to-width ra~io of about 0.~ facilitates such control of the migration of ions. These controls on ion migration are desirable to provide a more uniform transfer of ions from the entire bottom surface area of the gel into the person's skin.
That is, ion migration is stimulated to take place from the gel 16 over the shortest path to the skin, and migration laterally of ions to points of high current intensity for delivery into the skin is avoided.
A bottom cover 20 is placed in contact with the lower surface of the gel mate-rial 16 unt:il time of use of the bioelectrode to keep the gel free from con-tamination. The upper cover 4 and lower cover 20 thus completely enclose the gel material 16 until the bioelectrode is to be used. Then, the bottom cover 20 is simply peeled from the gel material and the gel material is placed in contact with the patient's skin or tissue. The cover 20 may be made of any suitable material such as plastic, treated paper, etc., which will maintain the gel mate-;l0 riaL 1~ free Erom contamination. Ears 20a and 20b are formed in the cover 20 to oxtend outwardly beyond the perlmeter oE the upper cover ~I to Eacilitate peeling the bottom cover from the gel material 16.
In use, the bioelectrode of FIGS. 1 and 2 is prepared with the ionic medicamentcarried in the gel material 16. The bioelectrode would then be delivered in a form generally as shown in the drawings and used as needed. In such use, as explained in the aforecited patents, the bioelectrode of FIG. 2 would be placed nglinst a person's skin with -the gel material 16 in contact with the skin.
Another electrode would be placed against the skin at a location spaced from -the Eirst electrode. Appropriate electric potentials would then be appllcd to eLoc~
trodes to creat.e a potential gradient between the electrode carrying the modlca-mont and tho sk:in.
I'IGS. 3 alld ~ show respectively a perspective view oE another cn~bodilllent o-E the presellt invelltloll tu~d a side, cross-sectional view thereof. In -this embodiment, a receptacle 28 for holding an ionic solution is formed of an upper wall 30 whose edges curve downwardly to join a bottom wall 34 (FIG. 4). The l upper wall 30 is constructed of a flexible, deformable material such as polyurethane suitable for holding an ionic solution to be delivered through the skin or tissue of a person. The bottom wall 34 is composed of a porous, micro-porous, permeable or semipermeable membrane materiai such asmicroporous polycarbonate, microporous polytetrafluoroethylene or polyacrylonitrile, through which the ions in the solution can pass to the person's skin.
Disposed in the upper wall 30 of the bioelectrode 28 is a male part of a metallic snap 38 similar to that described for FIGS. l and 2. The nipple of the snap 38 projects from the upper surface of the wall 30 to make electrical contact with a corresponding female part of a snap (or other suitable conductor). The snap 38 includes a base portion which is positioned at the bottom surface o~ the upper wall 30 in contact with a conductive sheet of material 42 which is affixed to the bottom surface of the wall 30. Temporarily affixed to the bottom surface of the bottom wall 34 is a sanitary cover 46 which, when the bioelectrode is to be used, is simply peeled off. While in place, the cover 46 maintains the bottom wall 34 free from contamination.
Disposed in the cavity 48 formed by the upper wall 30 and bottom wall 34 are a p~urality of partition walls 50 which extend from the foil 42 ~o the bottom wall 34. The partition walls 50 may be arranged in a variety of shapes to generally prevent mi~ration of ions laterally in the bioelqctrode receptacle. Three examples of the formation of partition ~alls in the bioelectrode are shown in FIGS. 5, 6 and 7.
In FI~. 5 partition walls 52 are shown in a grid pattern and defin~ a plurality of separate, cube-shaped compartments 54.
The material of the walls 52 is selected so as to prevent passage therethrough of the ions in the solution. Such material could be nonporous polyurethane. In FIG. 6, parti~ion 1 walls 56 are formed concentrically to define a plurality of annular compartments 58. The partition wall configuration of FIG. 5 prevents migration ofions in almost every lateral direction. The partition walls 56 in FrG. 6 prevent radial migration of ions but, of course, would not prevent a circumferential migration in each of the compartments. Other partition wall shapes, such as the spiral configuration of walls 60 shown in FIG. 7, could be devised to generally prevent lateral migration in the receptacle o the bioelectrode of FIGS. 3 and 4.
With the stxucture shown in FIGS. 3 through 7, ions are generally prevented from migrating in a direction parallel with the surface o the skin or tissue into which the ions are to be applie~ because of the positioning by the partition walls. Rather, the ions are constrained to migrate through the bottom wall 34 generally uniformly over the surface area of contact by the skin with the bottom wall. Also, with the configurations of FIGS.' 3-7, a given compartment in a device is allowed to deplete itself of ions and force con-duction through an adjacent compartment. Thus, when a given compartment is depleted of ions over a skin site of reduced impedance (i.e., burn, scratch, or other tissue damaye) the movement to an adjacent site of conduction thus reduces the likelihood of a serious burn taking place or minimi2es such burning or other tissue damage in the area of reduced ~issue impedance. Indeed the depletion of ions Erom one re~ion and the recruitment of an adjacent conduction site o~curs throughout the iontophore-tic treatment process in a continuous manner so that the total charge delivered to the skin is uniformly distributed to each area of the skin adjacent to the electrode surface. Such uniform current distribution and continuous recruitment of conduction sites operates to minimize iontophoretically induced burns.
:1 ~8~l~!Ln~4D
l In the manner described, ion~ophoretic bioelectrodes are provided wherein ion mobility is primarily limited to a direction normal to the surfaceof the skin or tissue into which the ions are to be applied. By so llmiting the mobility oE the ions, the likelihood of a concentration and delivery o~ ions a~ one or more points on the skin or tissue is avoided, and thus the likelihood of burns is reduced.
It sho.uld be understood that the above-defir.ed embodiments are only illustrative of the application of the principles of the present invention and that numerous other alternative embodiments could be described without departing from the spirit and scope of the invention. For example, the partition walls 50 of the embodiment of FIGS. 3 and 4 could take a variety of shapes to prevent the lateral migration of ions.
Also, various gel materials might be used in the FIGS. l and
IONTOPHORETIC BIOELECTRODE
This invention relates to an iontophoretic bioelectrode method and apparatus and more particularly to such a method and apparatus in wh.ich migration of ions from the apparatus to a person's skin or skin barrier is inhibited in certain direction~.
Iontophoresis is a technique of delivering ions into a pe-son's ~0 skin or tissue by placing a solution or other medium contain-ing the ions in contact with the skin, and applying electric current to the medium. The solution or medium containing the ions is typically carried by a first bioelectrode po.uch or receptacle. Ions are caused to migrate from the ion car.ryi.ng medium through the skin or tissue by the applicat.i.on of the electric current to the medium, and by placement against the.
skin o:E a second bioelectrode within some proximity oE the ~irst bioelectrode and the application of current of opposite polarity to the second bioelectrode. Th.is technique has been discussed in a number of prior art patent.s including U.S.
Patent No. 4,141,359 and 4,166,457. Examples of bioelectrodes which are generally useful for making electrical contact with the skin are described in UOS~ Patent Nos. 3,862,633 3,945,384 and 3,g73,557 o 1 There nave ~een several bioelectrGde proposals for carrying the ion solution or medium and placing it in pro~imity with the skin including provision o~ a receptacle with a wetable barrier on one side thereof. The wetable barrier or wall is covered until time of use and then uncovered for placement against the skin. T,hen, upon application of the electrical current, the lons migrate through the wall into the skin.
Another proposed arrangement involves the use of a receptacle ha~ing a microporous mem~rane on one side thereof which may be placed in contact with a person's skin. The membrane is selected so that it will not leak prior to use, but will allow migration of ions therethrough to the skin upon application of an electric current to the ion-carrying solution. With this arrangement, less care need be given to storage, trans-port and use of the receptacle since the ion containin~
fluid will not leak as it is used.
One of the principal problems with the prior art devices has been the problem of the bioelectrode producing burns at the site of application of medications. If the current to the bioel~ctrode is too high, the resistance of the skin or tissue may result in burns or other tissue damage. F~urther, once the skin or tissue is burned, the resistance at the site of the burn decreases allowing for an increase in current flow and thus ion migration at that site and this compo~mds the danger of serious burns to the skin or tissue. lf a blemish or cut ~xists somewhere at the location of contact of the bioelectrode with the skin or tissue, then the ions tend to migrate toward and concentrate at the blemish thereby increasing the danger of ~ burn at that site.
One approach to reducing the likelihood of burns to the skin or tissue is to simply reduce the amount of current applied ~5 to the bioelectrode. This, however, increases the treatment time for the patient since lower current flow requires longer 1 periods of applica'ion to reach the same degree of ion pen-etration. Of course, it would be desirable to both minimize the treatment time and minimize the likelihood of burns to the patient Erom the treatment.
It is an object of the invention to provide a new and improved bioelectrode for use in the ion~ophoretic delivery of ions into the skin or tissue of a personO
It is another object of the invention to provide such a bio-electrode in which the likelihood of burns to the skin or tissue is reduced It is a further object of the invention to provide such a bioelectrode wherein the lateral mobility of the ions in the elec-trode is inhibited.
It is an additional object of the invention to provide a bioelectrode for delivering ions into the skin or tissue of a person uniformly over a certain skin or tissue surface area regardless of local variations in skin impedance such as that caused by previous tissue damage.
It is also an object of the invention, in accordance with one aspect thereof to provide a bioelectrode adapted ~o minimize the chance of chemically induced iontophoretic ph burns.
The above and other objects of the invention are realized in a bioelectrode structure which includes a holder for hold-ing ions to be deLivered, one side of which is Eor placement against the person's skin or tissue. The holder is adapted to inhibit movement of ions in a direction yenerally parallel to the surface of the skin or tissue while allowing movement toward the side which is placed against the skin or tissue.
1 Also included is an elec~rically conduc~ive sheet of material a-ttached to and covering a substantial portion of ~he other side of the holder, and an electrical conductor coupled to the sheet of material for connection to an electrical source.
Electrlcal current is supplied ~y the conductor tv the sheet of materi.al to.cause the ions contained in the holder to migrate towards the side of the holder in contact with the skin. Since lateral movement of ions is inhibited by the holder (due to the longer current path lengths), the liKe~
lihood of burning is decreased since movement of ions to concentrate at one place is inhibited.
The holder can be adapted to inhibit the lateral movement of ions either by including structure within the holder to physically guide the ions or by proper selection and dimen-sioning of the ion holding material to enhance migration in one direction while inhibiting migration in another direction.
An example of the latter is gel material preloaded with ions.
By incorporation of an appropriate phosphate buffer in the gel material, chemically induced iontophoretic ph burns can better be avoided.
In the drawings:
The ahove and other objects, features and ad~antages of the inven~ion will become apparent from a consideration of the following detailed descrip-tion presented in connection with the accompanying drawings in which: 0 FIG. 1 is a perspective view of a bioelectrode made in accordance with the principl~-s of the present invention;
FIG~ 2 is a side, cross-sectional view of the bioelectrode 3~ of FIG. l;
1 FIG. 3 is a perspective view of another embodiment of the invention;
FIG. 4 is a side, cross-sectiGnal view of the bioelectrode of FIG. 3; -FIG. S is a top, cross-sectional view of one embodimant of the interior structure of the bioelectrode of FIG. 3;
FIG. 6 is a top, cross-sectional view of another embodiment of the interior structure of the bioelectrode o FIG. 3; and FIG. 7 is a top, cross-secti.onal view of still another ernbodiment of t;~e interior structure of -the bioelectrode of FIg. 3.
Referring now to the drawings:
Referring to the drawings there are shown several embodiments of an iontophoresis device made in accordance with the present invention. FIGS. 1 and 2 show a bioelectrode 2 composed o an upper cover 4 which may be made of pla~tic, treated paper, or other suitable covering material. Mounted in the co~er 4 is the male part 8 of a conventional metallic snap used on clothin~ and the like. The snap 8 includes an upwardly projecting nipple 8a which protrudes throuyh the cover 4 so that contact may be had with the corresponding female part o the snap or other suitable conductor. The nipple 8a is joined to a base portion 8b which is disposed on the under-neath side of the cover 4.
Afixed to the underneath side of the cover 4 in contact with the base portion 8b of the snap 8 is a piece of flexible foil 12 made of alumlnum ~r other electrically conductive rnaterial.
1 The foil 12 is in electrical contact with the snap 8 so that any electrical current applied to the snap 8 will flow to the foil 12. Affixed to the underneath side of the foil 12 is a sheet of iontophoresis gel 16 such as karaya g~lm, other pol~-S sacharide gels, or similar hydrophillic aqueous gels capableof carrying ions. Specific examples of such gels include polyvinyl alcohol, polymethyl pyrollidine, me~hyl cellulose, polyacrylamide, polyhemas, and polyhema derivatives, etc.
The perimeter of the gel 16 is substantially coterminous with the foil 12 as shown in the drawings. The gel selected should have nonirritating properties to avoid irrita~ing the person's skin or ~issue, sui.table viscosity and surfactant properties to ohtain good electrical contact with the skin or tissue, and the ability to act as a carrier mediwm for the ions. The lower surface of the gel 16 is for placement in contact with a person's skin or tissue for the iontophoretic treatment.
In order to minimize the chance of chemically induced ionto-phoretic ph burns in the surface tissues and the underlying tissues in the area of placement of the device, a phosphate buffer, such as mono-basic and/or di-basic sodium phosphate, is included in the gel material 16. Advantageously, a ph of about six will be provided in the gel.
The gel 16 is dimensioned so that ion migration is enhanced in a direction normal to the person's skin or tissue, and general~y inhibitied in a direction parallel to the person's skin. It has been found that a thickness-to-width ra~io of about 0.~ facilitates such control of the migration of ions. These controls on ion migration are desirable to provide a more uniform transfer of ions from the entire bottom surface area of the gel into the person's skin.
That is, ion migration is stimulated to take place from the gel 16 over the shortest path to the skin, and migration laterally of ions to points of high current intensity for delivery into the skin is avoided.
A bottom cover 20 is placed in contact with the lower surface of the gel mate-rial 16 unt:il time of use of the bioelectrode to keep the gel free from con-tamination. The upper cover 4 and lower cover 20 thus completely enclose the gel material 16 until the bioelectrode is to be used. Then, the bottom cover 20 is simply peeled from the gel material and the gel material is placed in contact with the patient's skin or tissue. The cover 20 may be made of any suitable material such as plastic, treated paper, etc., which will maintain the gel mate-;l0 riaL 1~ free Erom contamination. Ears 20a and 20b are formed in the cover 20 to oxtend outwardly beyond the perlmeter oE the upper cover ~I to Eacilitate peeling the bottom cover from the gel material 16.
In use, the bioelectrode of FIGS. 1 and 2 is prepared with the ionic medicamentcarried in the gel material 16. The bioelectrode would then be delivered in a form generally as shown in the drawings and used as needed. In such use, as explained in the aforecited patents, the bioelectrode of FIG. 2 would be placed nglinst a person's skin with -the gel material 16 in contact with the skin.
Another electrode would be placed against the skin at a location spaced from -the Eirst electrode. Appropriate electric potentials would then be appllcd to eLoc~
trodes to creat.e a potential gradient between the electrode carrying the modlca-mont and tho sk:in.
I'IGS. 3 alld ~ show respectively a perspective view oE another cn~bodilllent o-E the presellt invelltloll tu~d a side, cross-sectional view thereof. In -this embodiment, a receptacle 28 for holding an ionic solution is formed of an upper wall 30 whose edges curve downwardly to join a bottom wall 34 (FIG. 4). The l upper wall 30 is constructed of a flexible, deformable material such as polyurethane suitable for holding an ionic solution to be delivered through the skin or tissue of a person. The bottom wall 34 is composed of a porous, micro-porous, permeable or semipermeable membrane materiai such asmicroporous polycarbonate, microporous polytetrafluoroethylene or polyacrylonitrile, through which the ions in the solution can pass to the person's skin.
Disposed in the upper wall 30 of the bioelectrode 28 is a male part of a metallic snap 38 similar to that described for FIGS. l and 2. The nipple of the snap 38 projects from the upper surface of the wall 30 to make electrical contact with a corresponding female part of a snap (or other suitable conductor). The snap 38 includes a base portion which is positioned at the bottom surface o~ the upper wall 30 in contact with a conductive sheet of material 42 which is affixed to the bottom surface of the wall 30. Temporarily affixed to the bottom surface of the bottom wall 34 is a sanitary cover 46 which, when the bioelectrode is to be used, is simply peeled off. While in place, the cover 46 maintains the bottom wall 34 free from contamination.
Disposed in the cavity 48 formed by the upper wall 30 and bottom wall 34 are a p~urality of partition walls 50 which extend from the foil 42 ~o the bottom wall 34. The partition walls 50 may be arranged in a variety of shapes to generally prevent mi~ration of ions laterally in the bioelqctrode receptacle. Three examples of the formation of partition ~alls in the bioelectrode are shown in FIGS. 5, 6 and 7.
In FI~. 5 partition walls 52 are shown in a grid pattern and defin~ a plurality of separate, cube-shaped compartments 54.
The material of the walls 52 is selected so as to prevent passage therethrough of the ions in the solution. Such material could be nonporous polyurethane. In FIG. 6, parti~ion 1 walls 56 are formed concentrically to define a plurality of annular compartments 58. The partition wall configuration of FIG. 5 prevents migration ofions in almost every lateral direction. The partition walls 56 in FrG. 6 prevent radial migration of ions but, of course, would not prevent a circumferential migration in each of the compartments. Other partition wall shapes, such as the spiral configuration of walls 60 shown in FIG. 7, could be devised to generally prevent lateral migration in the receptacle o the bioelectrode of FIGS. 3 and 4.
With the stxucture shown in FIGS. 3 through 7, ions are generally prevented from migrating in a direction parallel with the surface o the skin or tissue into which the ions are to be applie~ because of the positioning by the partition walls. Rather, the ions are constrained to migrate through the bottom wall 34 generally uniformly over the surface area of contact by the skin with the bottom wall. Also, with the configurations of FIGS.' 3-7, a given compartment in a device is allowed to deplete itself of ions and force con-duction through an adjacent compartment. Thus, when a given compartment is depleted of ions over a skin site of reduced impedance (i.e., burn, scratch, or other tissue damaye) the movement to an adjacent site of conduction thus reduces the likelihood of a serious burn taking place or minimi2es such burning or other tissue damage in the area of reduced ~issue impedance. Indeed the depletion of ions Erom one re~ion and the recruitment of an adjacent conduction site o~curs throughout the iontophore-tic treatment process in a continuous manner so that the total charge delivered to the skin is uniformly distributed to each area of the skin adjacent to the electrode surface. Such uniform current distribution and continuous recruitment of conduction sites operates to minimize iontophoretically induced burns.
:1 ~8~l~!Ln~4D
l In the manner described, ion~ophoretic bioelectrodes are provided wherein ion mobility is primarily limited to a direction normal to the surfaceof the skin or tissue into which the ions are to be applied. By so llmiting the mobility oE the ions, the likelihood of a concentration and delivery o~ ions a~ one or more points on the skin or tissue is avoided, and thus the likelihood of burns is reduced.
It sho.uld be understood that the above-defir.ed embodiments are only illustrative of the application of the principles of the present invention and that numerous other alternative embodiments could be described without departing from the spirit and scope of the invention. For example, the partition walls 50 of the embodiment of FIGS. 3 and 4 could take a variety of shapes to prevent the lateral migration of ions.
Also, various gel materials might be used in the FIGS. l and
2 embodiment so long as appropriate dimensions were selected for such material 'o stimulate the desired migration direction and inhibit the undesirable lateral migration. The appended claims are intended to cover all described embodiments and alternative embodiments which the present invention might have.
Claims (13)
1. A bioelectrode for use in the iontophoretic delivery of ions into the skin or tissue of a person comprising means holding ions to be delivered, one side of which is for placement against the person's skin or tissue, said holding means being adapted to inhibit movement of ions in a direction generally parallel to the surface of the skin or tissue, an electrically conductive sheet of material disposed at a substantial portion of the other side of said holding means, and means for coupling said sheet of material to an electrical source.
2. A bioelectrode as in Claim 1 wherein said holding means comprises an ion mobility inhibiting gel layer having a thickness-to-width ratio of about 0.1 or less.
3. A bioelectrode as in Claim 2 wherein said gel layer is composed of a polysacharide gel.
4. A bioelectrode as in Claim 2 wherein said gel layer is composed of Karaya gum.
5. A bioelectrode as in Claim 2 further including a removable sheet of material covering said one side of the gel layer.
6. A bioelectrode as in Claim 2 wherein said sheet of material is a flexible metal or metal-alloy foil.
7. A bioelectrode as in Claim 2 wherein said gel layer includes a phosphate buffer.
8. A bioelectrode as in Claim 7 wherein the ph of said gel layer is about six.
9. A bioelectrode as in Claim 1 wherein said holding means comprises a receptacle having ion impermeable walls arranged to generally prevent migration of ions in a direction parallel to the surface of the skin or tissue.
10. A bioelectrode as in Claim 9 wherein said walls are formed generally perpendicular to said one side of the receptacle to define a multiplicity of compartments therein, said compartments thereby allowing migration one ions from the other side of said receptacle to said one side but preventing migration laterally of the walls.
11. A bioelectrode as in Claim 9 wherein said walls are formed generally perpendicular to said one side of the receptacle and in a spiral configuration to thereby allow migration of ions from the other side of said receptacle to said one side but prevent migration laterally of the walls.
12. A bioelectrode as in Claim 9 wherein said walls are formed generally perpendicular to said one side of the receptacle and in generally concentric rings to thereby allow migration of ions from the other side of said receptacle to said one side but prevent migration laterally of the walls.
13. A bioelectrode as in Claim 1 wherein said coupling means comprises the male part of a snap having a nipple which projects from the upper surface of said holding means, and a base portion joined to the nipple and electrically coupled to said sheet of material.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US236,753 | 1981-02-23 | ||
| US06/236,753 US4416274A (en) | 1981-02-23 | 1981-02-23 | Ion mobility limiting iontophoretic bioelectrode |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1181490A true CA1181490A (en) | 1985-01-22 |
Family
ID=22890809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000396679A Expired CA1181490A (en) | 1981-02-23 | 1982-02-19 | Ion mobility limiting iontophoretic bioelectrode |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4416274A (en) |
| EP (1) | EP0058920B1 (en) |
| JP (1) | JPS57168675A (en) |
| AT (1) | ATE20435T1 (en) |
| CA (1) | CA1181490A (en) |
| DE (1) | DE3271718D1 (en) |
Families Citing this family (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820263A (en) * | 1981-03-06 | 1989-04-11 | Medtronic, Inc. | Apparatus and method for iontophoretic drug delivery |
| JPS5810066A (en) * | 1981-07-10 | 1983-01-20 | 株式会社アドバンス | Plaster structure for ion tofuorese |
| US4477971A (en) * | 1981-11-06 | 1984-10-23 | Motion Control, Inc. | Iontophoretic electrode structure |
| US4465074A (en) * | 1982-04-20 | 1984-08-14 | Gilbert Buchalter | Method of applying an electrode to the skin of a patient |
| US4622031A (en) * | 1983-08-18 | 1986-11-11 | Drug Delivery Systems Inc. | Indicator for electrophoretic transcutaneous drug delivery device |
| US4557723A (en) * | 1983-08-18 | 1985-12-10 | Drug Delivery Systems Inc. | Applicator for the non-invasive transcutaneous delivery of medicament |
| US4731926A (en) * | 1985-02-19 | 1988-03-22 | Drug Delivery Systems Inc. | Method of manufacturing disposable and/or replenishable transdermal drug applicators |
| US5087240A (en) * | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| WO1986007269A1 (en) * | 1985-06-10 | 1986-12-18 | Drug Delivery Systems Inc. | Programmable control and mounting system for transdermal drug applicator |
| US5865786A (en) * | 1983-08-18 | 1999-02-02 | Drug Delivery Systems, Inc. | Programmable control and mounting system for transdermal drug applicator |
| US4708716A (en) * | 1983-08-18 | 1987-11-24 | Drug Delivery Systems Inc. | Transdermal drug applicator |
| US5591123A (en) * | 1983-08-18 | 1997-01-07 | Drug Delivery Systems Inc. | Programmable control mounting system for transdermal drug applicator |
| US5135479A (en) * | 1983-08-18 | 1992-08-04 | Drug Delivery Systems, Inc. | Programmable control and mounting system for transdermal drug applicator |
| US5135477A (en) * | 1984-10-29 | 1992-08-04 | Medtronic, Inc. | Iontophoretic drug delivery |
| CA1267937A (en) * | 1984-10-29 | 1990-04-17 | Joseph Bradley Phipps | Iontophoretic drug delivery |
| US4702732A (en) * | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
| AU591872B2 (en) * | 1985-06-10 | 1989-12-21 | Drug Delivery Systems Inc. | Programmable control and mounting system for transdermal drug applicator |
| US4722726A (en) * | 1986-02-12 | 1988-02-02 | Key Pharmaceuticals, Inc. | Method and apparatus for iontophoretic drug delivery |
| US4752285B1 (en) * | 1986-03-19 | 1995-08-22 | Univ Utah Res Found | Methods and apparatus for iontophoresis application of medicaments |
| US4915685A (en) * | 1986-03-19 | 1990-04-10 | Petelenz Tomasz J | Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange |
| US4886489A (en) * | 1986-03-19 | 1989-12-12 | Jacobsen Stephen C | Flow-through methods and apparatus for iontophoresis application of medicaments at a controlled pH |
| US6956032B1 (en) | 1986-04-18 | 2005-10-18 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US4734090A (en) * | 1986-07-18 | 1988-03-29 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator |
| US5961482A (en) * | 1986-07-25 | 1999-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
| US5042975A (en) * | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
| US4786277A (en) * | 1986-11-21 | 1988-11-22 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation |
| WO1988003821A1 (en) * | 1986-11-21 | 1988-06-02 | Boston University | Electrode assembly for transdermal drug delivery |
| US4731049A (en) * | 1987-01-30 | 1988-03-15 | Ionics, Incorporated | Cell for electrically controlled transdermal drug delivery |
| US5032109A (en) * | 1987-02-10 | 1991-07-16 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
| CA1317522C (en) * | 1987-03-20 | 1993-05-11 | Dan Sibalis | Transdermal drug delivery system |
| US5163899A (en) * | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| EP0313638A4 (en) * | 1987-05-15 | 1989-06-14 | Martin H Newman | Iontophoresis drug delivery system. |
| WO1989006989A1 (en) * | 1988-01-29 | 1989-08-10 | The Regents Of The University Of California | Iontophoretic non-invasive sampling or delivery device |
| US5362307A (en) * | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
| IL86076A (en) * | 1988-04-14 | 1992-12-01 | Inventor S Funding Corp Ltd | Transdermal drug delivery device |
| WO1989010690A1 (en) * | 1988-05-02 | 1989-11-16 | University Of South Florida | Method for electrofusing biological particles to tissues |
| US5057072A (en) * | 1988-10-28 | 1991-10-15 | Medtronic, Inc. | Iontophoresis electrode |
| CA2001444C (en) * | 1988-10-28 | 2000-07-25 | Darrel F. Untereker | Iontophoresis electrode |
| CA2001446C (en) * | 1988-10-28 | 2000-08-01 | Joseph Bradley Phipps | Iontophoresis electrode |
| US5087242A (en) * | 1989-07-21 | 1992-02-11 | Iomed, Inc. | Hydratable bioelectrode |
| US5374241A (en) * | 1989-07-21 | 1994-12-20 | Iomed, Inc. | Electrodes for iontophoresis |
| US5328455A (en) * | 1989-07-21 | 1994-07-12 | Iomed, Inc. | Rehydratable product and method of preparation thereof |
| US4994023A (en) * | 1989-08-08 | 1991-02-19 | Wellinghoff Stephen T | Electrochemical drug release and article |
| US4973303A (en) * | 1989-09-05 | 1990-11-27 | Empi, Inc. | pH buffered electrode for medical iontophoresis |
| US4950229A (en) * | 1989-09-25 | 1990-08-21 | Becton, Dickinson And Company | Apparatus for an electrode used for iontophoresis |
| US5084008A (en) * | 1989-12-22 | 1992-01-28 | Medtronic, Inc. | Iontophoresis electrode |
| US5088978A (en) * | 1990-01-26 | 1992-02-18 | Gensia Pharmaceuticals, Inc. | Apparatus and method for iontophoretic transfer |
| US6004309A (en) * | 1990-03-30 | 1999-12-21 | Alza Corporation | Method and apparatus for controlled environment electrotransport |
| US5125894A (en) * | 1990-03-30 | 1992-06-30 | Alza Corporation | Method and apparatus for controlled environment electrotransport |
| EP0533816B1 (en) * | 1990-06-15 | 1995-06-14 | Cortrak Medical, Inc. | Drug delivery apparatus |
| US5498238A (en) * | 1990-06-15 | 1996-03-12 | Cortrak Medical, Inc. | Simultaneous angioplasty and phoretic drug delivery |
| US5087241A (en) * | 1990-07-24 | 1992-02-11 | Empi, Inc. | Iontophoresis electrode with reservoir and injection site |
| US5160316A (en) * | 1990-09-10 | 1992-11-03 | Henley Julian L | Iontophoretic drug delivery apparatus |
| US5431625A (en) * | 1991-02-01 | 1995-07-11 | Empi, Inc. | Iontophoresis electronic device having a ramped output current |
| US5221254A (en) * | 1991-04-02 | 1993-06-22 | Alza Corporation | Method for reducing sensation in iontophoretic drug delivery |
| US5458568A (en) * | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
| US5310403A (en) * | 1992-05-18 | 1994-05-10 | Becton, Dickinson And Company | Iontophoretic drug delivery device and circuit therefor |
| US5310404A (en) * | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
| US5331979A (en) * | 1992-07-27 | 1994-07-26 | Henley Julian L | Iontophoretic cigarette substitute |
| US5807306A (en) * | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
| US5533971A (en) * | 1993-09-03 | 1996-07-09 | Alza Corporation | Reduction of skin irritation during electrotransport |
| US6327487B1 (en) * | 1995-05-04 | 2001-12-04 | Robert A. Stratbucker | Bioelectric interface |
| US5678545A (en) * | 1995-05-04 | 1997-10-21 | Stratbucker; Robert A. | Anisotropic adhesive multiple electrode system, and method of use |
| US6355025B1 (en) | 1995-06-07 | 2002-03-12 | Alza Corporation | Adjustable electrotransport drug delivery using a fixed output controller |
| US5788666A (en) * | 1995-06-15 | 1998-08-04 | Empi, Inc. | Iontophoresis electrode |
| US5840056A (en) * | 1995-06-15 | 1998-11-24 | Empi, Inc. | Iontophoresis electrode |
| US5989409A (en) * | 1995-09-11 | 1999-11-23 | Cygnus, Inc. | Method for glucose sensing |
| JP3459724B2 (en) * | 1996-03-17 | 2003-10-27 | 久光製薬株式会社 | Electrode device for iontophoresis |
| US6018679A (en) * | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
| US6139718A (en) | 1997-03-25 | 2000-10-31 | Cygnus, Inc. | Electrode with improved signal to noise ratio |
| US6231516B1 (en) | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
| US6163720A (en) * | 1997-12-18 | 2000-12-19 | Alza Corporation | Layered rate controlling membranes for use in an electrotransport device |
| EP0970719A3 (en) | 1998-07-08 | 2000-08-23 | Nitto Denko Corporation | Electrode structure |
| US6148231A (en) | 1998-09-15 | 2000-11-14 | Biophoretic Therapeutic Systems, Llc | Iontophoretic drug delivery electrodes and method |
| US6792306B2 (en) | 2000-03-10 | 2004-09-14 | Biophoretic Therapeutic Systems, Llc | Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor |
| US6477410B1 (en) | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
| US7127285B2 (en) | 1999-03-12 | 2006-10-24 | Transport Pharmaceuticals Inc. | Systems and methods for electrokinetic delivery of a substance |
| US7252655B2 (en) * | 1999-05-25 | 2007-08-07 | Iomed, Inc. | Ocular iontophoretic apparatus handle |
| US6319240B1 (en) | 1999-05-25 | 2001-11-20 | Iomed, Inc. | Methods and apparatus for ocular iontophoresis |
| US6539251B2 (en) | 1999-05-25 | 2003-03-25 | Iomed, Inc. | Ocular iontophoretic apparatus |
| US7162291B1 (en) * | 2000-03-01 | 2007-01-09 | Mirabel Medical Systems Ltd. | Uniform, disposable, interface for multi-element probe |
| US6629968B1 (en) | 2000-06-30 | 2003-10-07 | Vyteris, Inc. | Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode |
| US8788031B2 (en) * | 2001-09-21 | 2014-07-22 | Encore Medical Asset Corporation | Method and device for the iontophoretic delivery of a drug |
| JP4033382B2 (en) * | 2002-04-08 | 2008-01-16 | 久光製薬株式会社 | Insulin administration device |
| US8197844B2 (en) | 2007-06-08 | 2012-06-12 | Activatek, Inc. | Active electrode for transdermal medicament administration |
| US20080312579A1 (en) * | 2007-06-15 | 2008-12-18 | Transport Pharmaceuticals, Inc. | Method and system for mitigating current concentration in electrokinetic drug delivery |
| US8862223B2 (en) | 2008-01-18 | 2014-10-14 | Activatek, Inc. | Active transdermal medicament patch and circuit board for same |
| US7883487B2 (en) | 2008-06-16 | 2011-02-08 | Shantha Totada R | Transdermal local anesthetic patch with injection port |
| EP2874693A1 (en) * | 2012-07-20 | 2015-05-27 | Grünenthal GmbH | Electric-field assisted administration of tapentadol |
| CN103973058B (en) * | 2014-05-20 | 2016-08-17 | 江苏远中电机股份有限公司 | Blender asynchronous motor |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1360384A (en) * | 1964-08-17 | contact electrodes for ion therapy | ||
| US3474775A (en) * | 1967-02-27 | 1969-10-28 | William R Johnson | Electrode assembly for skin contact |
| US3567657A (en) * | 1968-05-29 | 1971-03-02 | Joseph Lichtenstein | Electrically conductive skin conditioning system |
| BE794361A (en) * | 1970-12-10 | 1973-07-23 | Thomas & Betts Corp | ELECTRODES INTENDED TO COME IN CONTACT WITH THE BODY THIN NON-METALLIC CURRENT DISTRIBUTION LAYER |
| US3741219A (en) * | 1971-11-24 | 1973-06-26 | R Sessions | Grounding place or electrode for electromedical equipment |
| US3848600A (en) * | 1972-02-03 | 1974-11-19 | Ndm Corp | Indifferent electrode in electrosurgical procedures and method of use |
| DE2440836A1 (en) * | 1974-08-26 | 1976-03-11 | Heinz Doering | Distributing plate for electrodes on skin surface - providing contact between electrode plate and skin surface is perforated plastics disc |
| US4125110A (en) * | 1975-11-25 | 1978-11-14 | Hymes Alan C | Monitoring and stimulation electrode |
| US4033334A (en) * | 1975-12-03 | 1977-07-05 | Nasa | Snap-in compressible biomedical electrode |
| US4164226A (en) * | 1976-08-25 | 1979-08-14 | Robert Tapper | Iontophoretic burn-protection electrode structure |
| US4211222A (en) * | 1976-08-25 | 1980-07-08 | Robert Tapper | Iontophoretic burn-protection method |
| CA1111503A (en) * | 1977-04-02 | 1981-10-27 | Isoji Sakurada | Biomedical electrode |
| DE2727396C3 (en) * | 1977-06-18 | 1983-12-08 | Beiersdorf Ag, 2000 Hamburg | Electrically conductive, viscoelastic gel |
| US4250878A (en) * | 1978-11-22 | 1981-02-17 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus and method |
| JPS55154032U (en) * | 1979-04-21 | 1980-11-06 |
-
1981
- 1981-02-23 US US06/236,753 patent/US4416274A/en not_active Expired - Lifetime
-
1982
- 1982-02-16 DE DE8282101141T patent/DE3271718D1/en not_active Expired
- 1982-02-16 EP EP82101141A patent/EP0058920B1/en not_active Expired
- 1982-02-16 AT AT82101141T patent/ATE20435T1/en not_active IP Right Cessation
- 1982-02-19 CA CA000396679A patent/CA1181490A/en not_active Expired
- 1982-02-23 JP JP57026921A patent/JPS57168675A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| EP0058920B1 (en) | 1986-06-18 |
| US4416274A (en) | 1983-11-22 |
| ATE20435T1 (en) | 1986-07-15 |
| EP0058920A1 (en) | 1982-09-01 |
| JPS57168675A (en) | 1982-10-18 |
| JPH0235584B2 (en) | 1990-08-10 |
| DE3271718D1 (en) | 1986-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1181490A (en) | Ion mobility limiting iontophoretic bioelectrode | |
| US5087240A (en) | Transdermal drug patch with conductive fibers | |
| US4921475A (en) | Transdermal drug patch with microtubes | |
| US5931804A (en) | Transdermal drug applicator and electrodes therefor | |
| US4919648A (en) | High tack drug patch | |
| EP0240593B1 (en) | Improved transdermal drug applicator and electrodes therefor | |
| US5651768A (en) | Transdermal drug applicator and electrodes therefor | |
| US4640689A (en) | Transdermal drug applicator and electrodes therefor | |
| KR940000071B1 (en) | Transdermal drug applicator | |
| US6129696A (en) | Transdermal drug applicator | |
| CA2022824C (en) | Apparatus for an electrode and method used for iontophoresis | |
| EP0147524B1 (en) | Applicator for the non-invasive transcutaneous delivery of medicament | |
| US5053001A (en) | Transdermal drug delivery device with multiple reservoirs | |
| US7383083B2 (en) | Transdermal delivery system (TDS) with electrode network | |
| EP0225556A3 (en) | Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same | |
| US4477971A (en) | Iontophoretic electrode structure | |
| JP2818050B2 (en) | Interface for iontophoresis | |
| IE910234A1 (en) | Iontophoretic Transfer Electrode And Method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |